1. Imprinting & Cancer group, Cancer Epigenetic & Biology Program (PEBC), Institut d'Investigació Biomedica de Bellvitge (IDIBELL), Avinguda Granvia, L'Hospitalet de Llobregat, Barcelona, Spain
2. Department of Maternal-Fetal Biology, National Research Institute for Child Health & Development, Tokyo, Japan
3. Department of Pediatrics, Hamamatsu University School of Medicine, Shizuoka, Japan
4. Fundación IVI-Instituto Universitario IVI- INCLIVA, Valencia, Spain
5. Igenomix SL, Valencia, Spain
6. Department of Obs/Gyn, Valencia University, Valencia, Spain
7. Department of Obs/Gyn, Stanford University, Palo Alto, CA 94305, USA
8. Cancer Epigenetics group, Cancer Epigenetic & Biology Program (PEBC), Institut d'Investigació Biomedica de Bellvitge (IDIBELL), Avinguda Granvia, L'Hospitalet de Llobregat, Barcelona, Spain
9. Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain
10. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain
11. Instituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz-UAM, Madrid, Spain
12. CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain
13. Department of Molecular Endocrinology, National Research Institute for Child Health & Development, Tokyo, Japan